Učitavanje...

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy

BACKGROUND: To evaluate the therapeutic efficacy of omalizumab and specific subcutaneous immunotherapy (SCIT) as a treatment modality in patients with more than one allergic-type condition. METHODS: In the first group (Group A), 2 males and 7 females with severe persistent asthma and a mean age of 3...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Yalcin, Arzu Didem, Kose, Sukran, Gorczynski, Reginald M.
Format: Artigo
Jezik:Inglês
Izdano: World Allergy Organization Journal 2012
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3512926/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.WOX.0000412027.16513.76
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!